Alonso-Garcia M, Martos-Barrachina F, Jimenez-Bueno S, Arce-Arnaez A, et al. Cost-benefit analysis of nirsevimab for respiratory syncytial virus prevention in infants: a population-based study. Eur J Pediatr 2026;185:551.
PMID: 42399582